The global digital respiratory device market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, which are major causes for respiratory diseases. The increasing awareness about COPD and asthma among people has led to an increase in the demand for digital respiratory devices. The global digital respiratory device market by type is segmented into sensors, smart inhalers, and nebulizers. The sensors segment accounted for the largest share in 2018 due to its wide range of applications such as monitoring lung function or detecting airway obstruction in patients with COPD or asthma. Smart inhalers are expected to witness significant growth during the forecast period owing to their ability to provide accurate doses of medication through a single breath delivery system that can be used by patients with COPD or asthma without any assistance from healthcare professionals. Nebulizers are also expected to witness significant growth during the forecast period owing primarily due their ability in delivering aerosolized medications directly into lungs without any assistance from healthcare professionals.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of respiratory diseases such as asthma and COPD is driving the demand for digital respiratory devices.
- The growing awareness about the benefits of digital respiratory devices over traditional ones is also driving the market growth.
- The increasing number of hospitals and clinics that are adopting digital respiratory devices to improve patient care is also a factor in market growth.
- Increasing government funding for research on digital respiratory devices will lead to more innovations in this field, which will drive the market growth in future years.
- Increasing focus on preventive healthcare by governments across the world will lead to increased spending on medical equipment, including digital respiratory devices, which will drive market growth.
Industry Growth Insights published a new data on “Digital Respiratory Device Market”. The research report is titled “Digital Respiratory Device Market research by Types (Sensors, Smart Inhalers, Nebulizers, Other), By Applications (Smart Inhalers and Nebulizers, Chronic Obstructive Pulmonary Disease (COPD), Other), By Players/Companies 3M Health Care, Adherium, Capsule Technologies, Cohero Health, Novartis AG, Propeller Health, Sensiron AG, Teva Pharmaceuticals Industries, Amiko Digital Health, AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Digital Respiratory Device Market Research Report
By Type
Sensors, Smart Inhalers, Nebulizers, Other
By Application
Smart Inhalers and Nebulizers, Chronic Obstructive Pulmonary Disease (COPD), Other
By Companies
3M Health Care, Adherium, Capsule Technologies, Cohero Health, Novartis AG, Propeller Health, Sensiron AG, Teva Pharmaceuticals Industries, Amiko Digital Health, AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Digital Respiratory Device Market Report Segments:
The global Digital Respiratory Device market is segmented on the basis of:
Types
Sensors, Smart Inhalers, Nebulizers, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Smart Inhalers and Nebulizers, Chronic Obstructive Pulmonary Disease (COPD), Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M Health Care
- Adherium
- Capsule Technologies
- Cohero Health
- Novartis AG
- Propeller Health
- Sensiron AG
- Teva Pharmaceuticals Industries
- Amiko Digital Health
- AstraZeneca
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline
Highlights of The Digital Respiratory Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sensors
- Smart Inhalers
- Nebulizers
- Other
- By Application:
- Smart Inhalers and Nebulizers
- Chronic Obstructive Pulmonary Disease (COPD)
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Digital Respiratory Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A digital respiratory device (DRD) is a medical device that helps people breathe more easily. DRDs can be used to help people with conditions like asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea.
Some of the major players in the digital respiratory device market are 3M Health Care, Adherium, Capsule Technologies, Cohero Health, Novartis AG, Propeller Health, Sensiron AG, Teva Pharmaceuticals Industries, Amiko Digital Health, AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline.
The digital respiratory device market is expected to grow at a compound annual growth rate of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Digital Respiratory Device Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Digital Respiratory Device Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Digital Respiratory Device Market - Supply Chain
4.5. Global Digital Respiratory Device Market Forecast
4.5.1. Digital Respiratory Device Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Digital Respiratory Device Market Size (000 Units) and Y-o-Y Growth
4.5.3. Digital Respiratory Device Market Absolute $ Opportunity
5. Global Digital Respiratory Device Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Digital Respiratory Device Market Size and Volume Forecast by Type
5.3.1. Sensors
5.3.2. Smart Inhalers
5.3.3. Nebulizers
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Digital Respiratory Device Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Digital Respiratory Device Market Size and Volume Forecast by Application
6.3.1. Smart Inhalers and Nebulizers
6.3.2. Chronic Obstructive Pulmonary Disease (COPD)
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Digital Respiratory Device Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Digital Respiratory Device Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Digital Respiratory Device Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Digital Respiratory Device Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Digital Respiratory Device Demand Share Forecast, 2019-2026
9. North America Digital Respiratory Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Digital Respiratory Device Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Digital Respiratory Device Market Size and Volume Forecast by Application
9.4.1. Smart Inhalers and Nebulizers
9.4.2. Chronic Obstructive Pulmonary Disease (COPD)
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Digital Respiratory Device Market Size and Volume Forecast by Type
9.7.1. Sensors
9.7.2. Smart Inhalers
9.7.3. Nebulizers
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Digital Respiratory Device Demand Share Forecast, 2019-2026
10. Latin America Digital Respiratory Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Digital Respiratory Device Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Digital Respiratory Device Market Size and Volume Forecast by Application
10.4.1. Smart Inhalers and Nebulizers
10.4.2. Chronic Obstructive Pulmonary Disease (COPD)
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Digital Respiratory Device Market Size and Volume Forecast by Type
10.7.1. Sensors
10.7.2. Smart Inhalers
10.7.3. Nebulizers
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Digital Respiratory Device Demand Share Forecast, 2019-2026
11. Europe Digital Respiratory Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Digital Respiratory Device Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Digital Respiratory Device Market Size and Volume Forecast by Application
11.4.1. Smart Inhalers and Nebulizers
11.4.2. Chronic Obstructive Pulmonary Disease (COPD)
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Digital Respiratory Device Market Size and Volume Forecast by Type
11.7.1. Sensors
11.7.2. Smart Inhalers
11.7.3. Nebulizers
11.7.4. Other
11.8. Bsis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Digital Respiratory Device Demand Share, 2019-2026
12. Asia Pacific Digital Respiratory Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Digital Respiratory Device Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Digital Respiratory Device Market Size and Volume Forecast by Application
12.4.1. Smart Inhalers and Nebulizers
12.4.2. Chronic Obstructive Pulmonary Disease (COPD)
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Digital Respiratory Device Market Size and Volume Forecast by Type
12.7.1. Sensors
12.7.2. Smart Inhalers
12.7.3. Nebulizers
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Digital Respiratory Device Demand Share, 2019-2026
13. Middle East & Africa Digital Respiratory Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Digital Respiratory Device Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Digital Respiratory Device Market Size and Volume Forecast by Application
13.4.1. Smart Inhalers and Nebulizers
13.4.2. Chronic Obstructive Pulmonary Disease (COPD)
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Digital Respiratory Device Market Size and Volume Forecast by Type
13.7.1. Sensors
13.7.2. Smart Inhalers
13.7.3. Nebulizers
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Digital Respiratory Device Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Digital Respiratory Device Market: Market Share Analysis
14.2. Digital Respiratory Device Distributors and Customers
14.3. Digital Respiratory Device Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M Health Care
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Adherium
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Capsule Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cohero Health
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novartis AG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Propeller Health
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sensiron AG
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Teva Pharmaceuticals Industries
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Amiko Digital Health
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. AstraZeneca
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Boehringer Ingelheim International GmbH
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. GlaxoSmithKline
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook